Report for Witkin JM

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders - Bruns_2017_Neuropharmacol_128_351
Author(s) : Bruns RF , Mitchell SN , Wafford KA , Harper AJ , Shanks EA , Carter G , O'Neill MJ , Murray TK , Eastwood BJ , Schaus JM , Beck JP , Hao J , Witkin JM , Li X , Chernet E , Katner JS , Wang H , Ryder JW , Masquelin ME , Thompson LK , Love PL , Maren DL , Falcone JF , Menezes MM , Zhang L , Yang CR , Svensson KA
Ref : Neuropharmacology , 128 :351 , 2017
Abstract : Bruns_2017_Neuropharmacol_128_351
ESTHER : Bruns_2017_Neuropharmacol_128_351
PubMedSearch : Bruns_2017_Neuropharmacol_128_351
PubMedID: 29102759

Title : Forebrain-selective AMPA-receptor antagonism guided by TARP gamma-8 as an antiepileptic mechanism - Kato_2016_Nat.Med_22_1496
Author(s) : Kato AS , Burris KD , Gardinier KM , Gernert DL , Porter WJ , Reel J , Ding C , Tu Y , Schober DA , Lee MR , Heinz BA , Fitch TE , Gleason SD , Catlow JT , Yu H , Fitzjohn SM , Pasqui F , Wang H , Qian Y , Sher E , Zwart R , Wafford KA , Rasmussen K , Ornstein PL , Isaac JT , Nisenbaum ES , Bredt DS , Witkin JM
Ref : Nat Med , 22 :1496 , 2016
Abstract : Kato_2016_Nat.Med_22_1496
ESTHER : Kato_2016_Nat.Med_22_1496
PubMedSearch : Kato_2016_Nat.Med_22_1496
PubMedID: 27820603

Title : M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine - Witkin_2014_J.Pharmacol.Exp.Ther_351_448
Author(s) : Witkin JM , Overshiner C , Li X , Catlow JT , Wishart GN , Schober DA , Heinz BA , Nikolayev A , Tolstikov VV , Anderson WH , Higgs RE , Kuo MS , Felder CC
Ref : Journal of Pharmacology & Experimental Therapeutics , 351 :448 , 2014
Abstract : Witkin_2014_J.Pharmacol.Exp.Ther_351_448
ESTHER : Witkin_2014_J.Pharmacol.Exp.Ther_351_448
PubMedSearch : Witkin_2014_J.Pharmacol.Exp.Ther_351_448
PubMedID: 25187432

Title : Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia - Chan_2008_Proc.Natl.Acad.Sci.U.S.A_105_10978
Author(s) : Chan WY , McKinzie DL , Bose S , Mitchell SN , Witkin JM , Thompson RC , Christopoulos A , Lazareno S , Birdsall NJ , Bymaster FP , Felder CC
Ref : Proc Natl Acad Sci U S A , 105 :10978 , 2008
Abstract : Chan_2008_Proc.Natl.Acad.Sci.U.S.A_105_10978
ESTHER : Chan_2008_Proc.Natl.Acad.Sci.U.S.A_105_10978
PubMedSearch : Chan_2008_Proc.Natl.Acad.Sci.U.S.A_105_10978
PubMedID: 18678919

Title : Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior - Collins_2005_J.Pharmacol.Exp.Ther_314_310
Author(s) : Collins GT , Witkin JM , Newman AH , Svensson KA , Grundt P , Cao J , Woods JH
Ref : Journal of Pharmacology & Experimental Therapeutics , 314 :310 , 2005
Abstract : Collins_2005_J.Pharmacol.Exp.Ther_314_310
ESTHER : Collins_2005_J.Pharmacol.Exp.Ther_314_310
PubMedSearch : Collins_2005_J.Pharmacol.Exp.Ther_314_310
PubMedID: 15833897

Title : Effects of some antimuscarinics alone and in combination with chlordiazepoxide on punished and nonpunished behavior of rats - Witkin_1991_Pharmacol.Biochem.Behav_39_453
Author(s) : Witkin JM , Witkin KM
Ref : Pharmacol Biochem Behav , 39 :453 , 1991
Abstract : Witkin_1991_Pharmacol.Biochem.Behav_39_453
ESTHER : Witkin_1991_Pharmacol.Biochem.Behav_39_453
PubMedSearch : Witkin_1991_Pharmacol.Biochem.Behav_39_453
PubMedID: 1946585

Title : Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine - Genovese_1990_Pharmacol.Biochem.Behav_37_117
Author(s) : Genovese RF , Elsmore TF , Witkin JM
Ref : Pharmacol Biochem Behav , 37 :117 , 1990
Abstract : Genovese_1990_Pharmacol.Biochem.Behav_37_117
ESTHER : Genovese_1990_Pharmacol.Biochem.Behav_37_117
PubMedSearch : Genovese_1990_Pharmacol.Biochem.Behav_37_117
PubMedID: 2263653

Title : Physostigmine-insensitive behavioral excitatory effects of atropine in squirrel monkeys - Witkin_1989_Pharmacol.Biochem.Behav_32_309
Author(s) : Witkin JM , Markowitz RA , Barrett JE
Ref : Pharmacol Biochem Behav , 32 :309 , 1989
Abstract : Witkin_1989_Pharmacol.Biochem.Behav_32_309
ESTHER : Witkin_1989_Pharmacol.Biochem.Behav_32_309
PubMedSearch : Witkin_1989_Pharmacol.Biochem.Behav_32_309
PubMedID: 2734342

Title : 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent - Carroll_1987_J.Med.Chem_30_805
Author(s) : Carroll FI , Abraham P , Parham K , Griffith RC , Ahmad A , Richard MM , Padilla FN , Witkin JM , Chiang PK
Ref : Journal of Medicinal Chemistry , 30 :805 , 1987
Abstract : Carroll_1987_J.Med.Chem_30_805
ESTHER : Carroll_1987_J.Med.Chem_30_805
PubMedSearch : Carroll_1987_J.Med.Chem_30_805
PubMedID: 3494849

Title : Comparison of in vitro actions with behavioral effects of antimuscarinic agents - Witkin_1987_J.Pharmacol.Exp.Ther_242_796
Author(s) : Witkin JM , Gordon RK , Chiang PK
Ref : Journal of Pharmacology & Experimental Therapeutics , 242 :796 , 1987
Abstract : Witkin_1987_J.Pharmacol.Exp.Ther_242_796
ESTHER : Witkin_1987_J.Pharmacol.Exp.Ther_242_796
PubMedSearch : Witkin_1987_J.Pharmacol.Exp.Ther_242_796
PubMedID: 3498817